Since 2010, two significant international regulations regarding medical device development have come into force, the amendment to the European Union (EU) Medical Device Directive (MDD) 2007/47/EC and the United States (US) Food and Drug Administration (FDA) final rule on Medical Device Data Systems (MDDS). Adherence to these regulations is mandatory to be able to market a medical device in the respective region. The ability to understand these regulations and apply them to a development project can be difficult. The MDDS final rule changes the safety classification of a number of devices from Class III-high risk to Class I-low risk. The aim of this regulation is to make the process of achieving regulatory approval for manufacturers easier. The MDD aims to provide guidance for the development of medical devices to be marketed for use within the EU. It also provides defined pathways which manufacturers can follow in order to achieve regulatory approval. However, changes made as part of an amendment to the directive have a direct impact on the development of medical devices. One of the most significant changes as part of this amendment is for software to be potentially considered as a medical device in its own right and potentially the only element in a medical device subject to regulatory conformance. These regulations have created confusion surrounding specific areas, such as the use of mobile device applications for healthcare purposes. This article describes the key points of these latest regulatory changes that medical device manufacturers need to be aware of.
Skip Nav Destination
e-mail: Martin.McHugh@dkit.ie
e-mail: Fergal.McCaffery@dkit.ie
e-mail: Val.Casey@dkit.ie
Article navigation
June 2012
Research Papers
Changes to the International Regulatory Environment
Martin McHugh,
Martin McHugh
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
e-mail: Martin.McHugh@dkit.ie
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
Search for other works by this author on:
Fergal McCaffery,
Fergal McCaffery
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
e-mail: Fergal.McCaffery@dkit.ie
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
Search for other works by this author on:
Valentine Casey
Valentine Casey
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
e-mail: Val.Casey@dkit.ie
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
Search for other works by this author on:
Martin McHugh
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
e-mail: Martin.McHugh@dkit.ie
Fergal McCaffery
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
e-mail: Fergal.McCaffery@dkit.ie
Valentine Casey
Regulated Software Research Group & Lero, Department of Mathematics and Computing,
Dundalk Institute of Technology
, Dundalk Co. Louth, Ireland
e-mail: Val.Casey@dkit.ie
J. Med. Devices. Jun 2012, 6(2): 021004 (4 pages)
Published Online: April 26, 2012
Article history
Received:
August 5, 2011
Revised:
February 22, 2012
Online:
April 26, 2012
Published:
April 26, 2012
Citation
McHugh, M., McCaffery, F., and Casey, V. (April 26, 2012). "Changes to the International Regulatory Environment." ASME. J. Med. Devices. June 2012; 6(2): 021004. https://doi.org/10.1115/1.4006592
Download citation file:
Get Email Alerts
Cited By
Related Articles
Information in Order
Mechanical Engineering (September,2004)
Children and Adults With Rare Diseases Need Innovative Medical Devices
J. Med. Devices (September,2018)
Automated Real-Time Processing of Single Lead Electrocardiogram for Simultaneous Heart Rate and Respiratory Rate Monitoring
J. Med. Devices (June,2017)
A Not-Motorized Implantable Device for Partial Circulatory Support: A Proof of Concept Experiment
J. Med. Devices (December,2018)
Related Proceedings Papers
Related Chapters
QRAS Approach to Phased Mission Analysis (PSAM-0444)
Proceedings of the Eighth International Conference on Probabilistic Safety Assessment & Management (PSAM)
Regulatory perspectives
Biocompatible Nanomaterials for Targeted and Controlled Delivery of Biomacromolecules
Regulation of Vascular Grafts
Vascular Graft Update: Safety and Performance